Scientific Basis for the Treatment of Parkinson's Disease, 2nd edn.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In Parkinson's disease, earlier loss of locus coeruleus neurons in the pons alters mood, sleep, and posture.
“Lower, in the pons, an earlier loss of neurons in the locus coeruleus alters mood, sleep, and posture.”
From Chemiexcitation: Mammalian Photochemistry in the Dark<sup>†</sup> (2023) · cites this paper as [201]
Parkinson's disease patients lose neurons in the raphe nuclei of the reticular formation and the dorsal motor nucleus of the vagus.
“Still lower in the brainstem, PD patients lose neurons in the raphe nuclei of the reticular formation (regulating mood and depression) and the dorsal motor nucleus of the vagus (controlling vocal cords and swallowing).”
From Chemiexcitation: Mammalian Photochemistry in the Dark<sup>†</sup> (2023) · cites this paper as [201]
Multiple system atrophy and progressive supranuclear palsy both result from neuron death in the substantia nigra, locus coeruleus, raphe nuclei, and dorsal nucleus of the vagus, plus additional brain nuclei where neuromelanin may not be a factor.
“Despite having very different clinical signs, both result from neuron death in the substantia nigra, locus coeruleus, raphe nuclei, and dorsal nucleus of the vagus, plus additional brain nuclei where neuromelanin may not be a factor (201).”
From Chemiexcitation: Mammalian Photochemistry in the Dark<sup>†</sup> (2023) · cites this paper as [201]
Cited by
Sorted by citations
Chemiexcitation: Mammalian Photochemistry in the Dark<sup>†</sup>
Brash, D. E., & Goncalves, L. C. P. (2023) · Photochemistry and Photobiology · doi:10.1111/php.13781 · Cited by 16 · see citing works
- Authors
- Jellinger, K. A.
- Corresponding author
- Jellinger, K. A.
- ORCID
- Jellinger, K. A.
- Venue
- European Journal of Neurology
- Publisher
- Wiley
- Published
- 2005-08-26
- Volume
- 12
- Issue
- 9
- Pages
- 741-741
- ISSN
- 1351-5101 (ISSN-L)
- 1468-1331
- OpenAlex
- W2017522575
- Cited by
- 0
- References
- 0
- Type
- book review
- Language
- en
- Open access
- closed
- Locations
- European Journal of Neurology (publishedVersion)
- Topics
- Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Neurology › Neurological disorders and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nuclear Receptors and Signaling
- Keywords
- Parkinson's disease, treatment, pharmacotherapy, neurodegeneration
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
